|

Interleukin23 in Systemic Lupus

RECRUITINGN/ASponsored by Sohag University
Actively Recruiting
PhaseN/A
SponsorSohag University
Started2025-05-01
Est. completion2025-08-01
Eligibility
Age18 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06713187

Summary

assement of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease .

Eligibility

Age: 18 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* patients with systemic lupus erythematous and patients with systemic lupus erythematosus with interstial lung disease.

Exclusion Criteria:

* patients with chest conditions rather than interstial lung disease \&who receiving biological blocking antibodies\& those treated with immunosuppressive drugs.

Conditions2

LupusSystemic Lupus Erythematosus Related Interstial Lung Disease

Browse More Trials

Lupus trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.